Navigation Links
Rapid-response Technology from NeuroInterventions, Inc. Aims to Quickly Restore Brain's Blood Flow After a Stroke
Date:9/13/2009

PITTSBURGH, Sept. 14 /PRNewswire/ -- Driven by the emergency-room maxim, "Time is brain," NeuroInterventions, Inc. is prototyping an innovative stroke treatment device designed to speed up the restoration of blood flow and thus minimize brain damage.

Michele Migliuolo, NeuroInterventions President and COO, will describe the development and his company's background in a presentation at the 3 Rivers Venture Fair in Pittsburgh on Sept. 16.

"In stroke treatment, every lost second means decreased brain function," he says. When a blood clot plugs an artery, blocking the flow of oxygen-rich blood to part of the brain, "the 'window' during which surgery can help is just a matter of hours."

"But, even after a patient reaches a hospital, it can take as long as 60 minutes just to introduce a conventional catheter through the femoral artery and steer it to the site, before you can start to deal with the clot."

NeuroInterventions systems can dissolve or extract clots and, if necessary, deliver medication. Among the key innovations are a shorter, faster path to the brain, and exceptional maneuverability for negotiating the circulatory system's complexities. "Our devices will benefit patients, physicians, hospitals and insurance companies by improving outcomes through shorter, more effective treatment; by permitting more complex procedures; and by reducing recovery times," Dr. Migliuolo says.

Founded in 2007 and based in Pittsburgh, NeuroInterventions is prototyping a family of patent-pending catheters for addressing conditions that include deep vein thrombosis, carotid stenting, traumatic brain injury, and stroke. The technology also facilitates localized drug and stem cell delivery.

The management team includes world leaders in interventional radiology, neurology and neurosurgery, as well as successful entrepreneurs, among them:
'/>"/>

SOURCE NeuroInterventions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Winner Medicals Shenzhen Subsidiary Obtained High and New Technology Enterprise Certificate
2. RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products
3. BlueSky Synergy, a Division of Amistaff Healthcare Technology, and People 2.0 Global Partner to Provide Complimentary Staffing Software to Participating Companies
4. LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL(TM) Technology
5. Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology
6. Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology
7. Kapstone Medical Acquires Exclusive License to New Orthopedic Technology
8. Technologies That Redefine Care for Older Americans to be Focus of Conference Session Led by Center for Technology and Aging
9. Methodist Health System Selects Webmedx for Medical Transcription Technology and Services
10. Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution
11. Koshland Science Museum explores emerging technology in fall programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Hispanics develop alcoholic liver disease (ALD), ... 12 years earlier than Whites/Caucasians or African Americans, according ... , While previous research indicated that Hispanics tend to ... study -- published online in the journal Alcoholism: Clinical ... first to pinpoint racial and ethnic disparities in the ...
(Date:2/27/2015)... Beverly Hills, CA (PRWEB) February 27, 2015 ... was in the air for those suffering from Sjögren’s ... had been discovered by researchers at the University of ... the next phase of research was to develop a ... to precisely detect the presence of new autoantibodies. Researchers ...
(Date:2/27/2015)... Clinovo, a leading provider of cloud-based eClinical ... (EDC) at the CALBIO2015 conference taking place ... 3rd at Booth # 141. , ClinCapture ... edit-check builder allowing Clinical Trials Managers to create CRFs ... any programming experience. Clinovo’s new pricing model offers a ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 In honor of American ... Primary Care (CPC) South office, is offering tips on how to ... of death, but that doesn't mean people have to accept it ... some risk factors — such as family history, sex or age ... , Dr. Scott has six helpful tips to improve heart ...
(Date:2/27/2015)... February 27, 2015 The federal court ... that allege use of the statin medication can increase ... issued a new order pertaining discovery in the cases ... Liebhard LLP comments. The Order, which was issued in ... February 25th, directs the parties to schedule certain witness ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3
... , ST. PAUL, Minn., Dec. 10 /PRNewswire-USNewswire/ -- ... their 6th annual blood drive event with the Minnesota Vikings ... at the St. Paul Donor Center (I-94 and Hwy. 280), ... cheerleaders scheduled to arrive around 2 PM. All presenting ...
... ... announces that, after a national search, the Board of Trustees of Abington Health voted to ... ... H. Durham, chairman, Board of Trustees of Abington Health and Abington Memorial Hospital, announces that, ...
... , ARLINGTON, Va., Dec. 10 Americans ... but are highly aware of the risks of not receiving care, ... Mental Illness (NAMI). , See full survey results at ... people of diverse communities. , Though depression is common and highly ...
... , Helps PSI, DFID and USAID highlight progress in ... 10 Emmy Award winning actress and PSI (Population Services ... and individuals who have contributed to the substantial decline in ... six years Zimbabwe has seen a dramatic reduction in the ...
... the emissions leaving a car tailpipe or factory smokestack affect ... the atmosphere. But until now, scientists have struggled to know ... once they leave their source, leading to models for predicting ... accurate. A major collaborative effort of more than ...
... Pennsylvania School of Medicine have developed a new model of ... molecule called Src kinase is activated in human skin-cancer samples. ... are activated in human squamous cell carcinomas of the skin. ... gene Fyn, a member of Src family of proteins, in ...
Cached Medicine News:Health News:Minnesota Vikings Team With Memorial Blood Centers Again for Annual Blood Drive 2Health News:Abington Health Announces New President and CEO 2Health News:Abington Health Announces New President and CEO 3Health News:Depression Survey: Implications for Diverse Communities 2Health News:Emmy Award Winning Actress Debra Messing Visits Zimbabwe 2Health News:Emmy Award Winning Actress Debra Messing Visits Zimbabwe 3Health News:New approach to emissions makes climate and air quality models more accurate, major study finds 2Health News:New approach to emissions makes climate and air quality models more accurate, major study finds 3Health News:New model of skin cancer provides insights on second-most common type of cancer 2
(Date:2/27/2015)... LONDON , February 27, 2015 ... - new study showing you trends, R&D progress, and ... medicine heading? What are the commercial prospects for ... shows you potential revenues and other trends to 2025, ... ,s report lets you assess regenerative medicine : ...
(Date:2/27/2015)... - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), ... for its first quarter ended December 31, 2014. ... 2014, revenue was $1,336,685. Operating expenses were $1,063,393.  Net ... share.  Covalon,s President and CEO, ... the significant progress we have made over the past ...
(Date:2/27/2015)... , February 27, 2015 ... bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz (CHF) in ...     ... ein neuartiges Herzüberwachungssystem für Patienten mit kongestiver ... dass sie ein Finanzierungsvorhaben über 5 Mio. ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2
... 28, 2010 /PRNewswire-Asia/ -- Chindex International, Inc. ("Chindex") ... American provider of Western healthcare products and services ... Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"), a ... medicine and devices in China, today announced the ...
... that new in-demand ResearchInChina reports on China industries ... Beer Industry Report, 2009-2010 . The report discusses development of ... in China. The study provides data on sales volume and ... product features and marketing strategies. China ...
Cached Medicine Technology:Chindex and Fosun Pharma Form Joint Venture 2Chindex and Fosun Pharma Form Joint Venture 3Chindex and Fosun Pharma Form Joint Venture 4Chindex and Fosun Pharma Form Joint Venture 5Topical China Industries Research Reports Published at MarketPublishers.com 2
Ideal for abdominal and back procedures....
Female High Waist Briefs...
Provides upper and lower arm support. Extends to the lower arm and across the shoulders. Has two columns of hook & eye closure for added adjustability....
Short-Sleeve Bolero for targeted compression in the upper arms, back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
Medicine Products: